Terms: = Breast cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Diagnosis
10 results:
1. A novel body composition risk score (B-Score) and overall survival among patients with nonmetastatic breast cancer.
Cheng E; Caan BJ; Chen WY; Prado CM; Cespedes Feliciano EM
Clin Nutr; 2024 Apr; 43(4):981-987. PubMed ID: 38471402
[TBL] [Abstract] [Full Text] [Related]
2. Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: The African breast cancer-Disparities in Outcomes Cohort Study.
Togawa K; Anderson BO; Foerster M; Galukande M; Zietsman A; Pontac J; Anele A; Adisa C; Parham G; Pinder LF; McKenzie F; Schüz J; Dos Santos-Silva I; McCormack V
Int J Cancer; 2021 May; 148(9):2212-2226. PubMed ID: 33197280
[TBL] [Abstract] [Full Text] [Related]
3. A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer.
Legg M; Hyde MK; Occhipinti S; Youl PH; Dunn J; Chambers SK
Support Care Cancer; 2019 Feb; 27(2):677-685. PubMed ID: 30056530
[TBL] [Abstract] [Full Text] [Related]
4. Distribution of HLA antigens in breast cancer.
Bayraktar B; Yilmaz E; Bayraktar O; Apaydin BB; Erguner IE; Kayabasi B; Ozcelik AA; Eren B
Bratisl Lek Listy; 2012; 113(6):372-5. PubMed ID: 22693975
[TBL] [Abstract] [Full Text] [Related]
5. A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E; Martorelli D; Turchet E; Miolo G; Scalone S; Comaro E; Talamini R; Mastorci K; Lombardi D; Perin T; Carbone A; Veronesi A; Crivellari D; Dolcetti R
Breast Cancer Res; 2011; 13(6):R117. PubMed ID: 22112244
[TBL] [Abstract] [Full Text] [Related]
6. [cancer mortality in Southern Italy, 1999-2003].
Bidoli E; Montella M; Bruzzone S; De Paoli A; Fusco M; Frova L; Pace M; Pappagallo M; Serraino D
Epidemiol Prev; 2011; 35(3-4):200-6. PubMed ID: 21914916
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract] [Full Text] [Related]
8. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract] [Full Text] [Related]
9. Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions.
Magyarosy E; Martin WJ; Chu EW; Martin SE
Pathol Oncol Res; 1999; 5(1):32-5. PubMed ID: 10079375
[TBL] [Abstract] [Full Text] [Related]
10. HLA and prognostic factors in primary breast cancer.
Iaffaioli RV; Maio M; Ruggiero G; De Felice M; Ungaro A; Del Vecchio L; Rosato GB; Bianco AR; Zappacosta S
Int J Cancer; 1985 May; 35(5):581-5. PubMed ID: 3873417
[TBL] [Abstract] [Full Text] [Related]
